US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.65 against a street estimate of 0.69 — a miss of 5.8%.
Analysts rate LeMaitre Vascular Inc a buy (4 buy, 4 hold, 0 sell out of 8) with an average price target of $107.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.31% |
| Conestoga Capital Advisors, LLC | 5.98% |
| First Trust Advisors L.P. | 4.78% |
| Congress Asset Management Company, LLP | 4.21% |
| Vanguard Capital Management, LLC | 4.17% |
| Copeland Capital Management, LLC | 4.04% |
| State Street Corp | 3.94% |
| Geode Capital Management, LLC | 3.45% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 net sales were $67,970, up from $61,046 in the third quarter of 2025. • Nine-month 2026 net sales were $204,90 | 2026-11-05 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 sales were $68.0mm, up 11% year over year and 12% organically. • Gross margin was 71.7%, down 360 basis points reported bu | 2026-11-04 |
| Board / officer change · Q4 2026 HEADLINE NUMBERS • David B. Roberts will retire as an employee and as President of LeMaitre Vascular effective December 31, 2026. • Roberts has serv | 2026-10-15 |
| Quarterly report · Q2 2026 LEMAITRE VASCULAR, INC. — 10-Q SUMMARY (Q2 2026) --- HEADLINE NUMBERS • Net sales Q2 2026: $70.4 million (up 9.6% vs. $64.2M in Q2 2025) • Net sale | 2026-08-05 |
| Results announced · Q3 2026 LEMAITRE VASCULAR Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 sales: $70.4mm, up 10% year-over-year (10% organic growth) • Gross ma | 2026-08-04 |
| Shareholder vote results · Q2 2026 LEMAITRE VASCULAR, INC. - 8-K SUMMARY HEADLINE NUMBERS • Voting shares: 22,847,798 shares entitled to vote as of April 6, 2026 record date • Shareho | 2026-06-05 |
| Quarterly report · Q1 2026 LEMAITRE VASCULAR, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net sales: $66.6 million (Q1 2026) vs. $59.9 million (Q1 2025) — 11.2% increase • | 2026-05-06 |
| Results announced · Q2 2026 LEMAITRE VASCULAR Q1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q1 2026 sales: $66.6 million, +11% vs Q1 2025 (+10% organic growth) • Gross m | 2026-05-05 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.25 / share ex-date Aug 20, 2026 · pay Sep 3, 2026 | 2026-08-20 |
| Dividend | $0.25 / share ex-date May 21, 2026 · pay Jun 4, 2026 | 2026-05-21 |
| Dividend | $0.25 / share ex-date Mar 12, 2026 · pay Mar 26, 2026 | 2026-03-12 |
| Dividend | $0.20 / share ex-date Nov 20, 2025 · pay Dec 4, 2025 | 2025-11-20 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for LeMaitre Vascular Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.